Operating Lease, Right-of-Use Asset of AbCellera Biologics Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AbCellera Biologics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • AbCellera Biologics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $136,117,000, a 104% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AbCellera Biologics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $136,117,000 +$69,468,000 +104% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $137,914,000 +$69,595,000 +102% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $136,935,000 +$66,779,000 +95% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $68,736,000 -$2,590,000 -3.6% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $66,649,000 -$6,492,000 -8.9% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $68,319,000 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $70,156,000 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $71,326,000 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $73,141,000 -$7,697,000 -9.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $80,838,000 31 Dec 2022 10-K 20 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.